Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Classifica tra le azioni #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Prezzo delle azioni
$0.49606484
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$88.47M
Variazione (1 giorno)
-1.58%
Variazione (1 anno)
-22.51%
Paese
TW
Scambia Intech Biopharm Corporation (6461)

Categoria

Storico del prezzo dell'azione per Intech Biopharm Corporation (6461)
Prezzo di chiusura più alto: $0.51 il 2026-08-01

Prezzo di chiusura più basso: $2.53 il 2014-07-01
Storico del prezzo dell'azione di Intech Biopharm Corporation dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 14.95%
2025 -41.62%
2024 -9.11%
2023 -16.45%
2022 54.36%
2021 -3.00%
2020 22.52%
2019 -6.95%
2018 -49.08%
2017 20.07%
2016 -28.29%
2015 0.41%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH